Opna Bio
Oncology pharmaceutical company
Epalinges, Switzerland · Founded 2018 · $38.0M raised
- Headquarters
- Epalinges
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- opnabio.com
- Total Funding
- $38.0M
- Last Round
- $38.0M Series ANov 2022
- Rounds
- 1
About
Clinical-stage biopharmaceutical company discovering and developing novel oncology therapeutics for cancer patients.
Summary
Opna Bio is a Biotech company based in Epalinges, Switzerland, founded in 2018. It has raised $38.0M in total across 1 round, most recently a $38.0M Series A round in Nov 2022. Investors include Longitude Capital, Northpond Ventures and Menlo Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/opna-bio"><img src="https://indexed.vc/api/badge/company/opna-bio" alt="Opna Bio on Indexed.vc" width="260" height="76" /></a>